Canada Life’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $554K | Hold |
19,219
| – | – | ﹤0.01% | 1578 |
|
2025
Q1 | $646K | Hold |
19,219
| – | – | ﹤0.01% | 1554 |
|
2024
Q4 | $981K | Buy |
19,219
+1,880
| +11% | +$96K | ﹤0.01% | 1470 |
|
2024
Q3 | $887K | Hold |
17,339
| – | – | ﹤0.01% | 1543 |
|
2024
Q2 | $776K | Buy |
17,339
+12,597
| +266% | +$564K | ﹤0.01% | 1568 |
|
2024
Q1 | $222K | Hold |
4,742
| – | – | ﹤0.01% | 1815 |
|
2023
Q4 | $168K | Hold |
4,742
| – | – | ﹤0.01% | 1862 |
|
2023
Q3 | $141K | Buy |
4,742
+3,285
| +225% | +$97.7K | ﹤0.01% | 1907 |
|
2023
Q2 | $26K | Hold |
1,457
| – | – | ﹤0.01% | 2095 |
|
2023
Q1 | $23K | Hold |
1,457
| – | – | ﹤0.01% | 2181 |
|
2022
Q4 | $27K | Hold |
1,457
| – | – | ﹤0.01% | 2201 |
|
2022
Q3 | $29K | Hold |
1,457
| – | – | ﹤0.01% | 2189 |
|
2022
Q2 | $27K | Hold |
1,457
| – | – | ﹤0.01% | 2201 |
|
2022
Q1 | $34K | Hold |
1,457
| – | – | ﹤0.01% | 2247 |
|
2021
Q4 | $41K | Hold |
1,457
| – | – | ﹤0.01% | 2219 |
|
2021
Q3 | $31K | Hold |
1,457
| – | – | ﹤0.01% | 2350 |
|
2021
Q2 | $27K | Buy |
+1,457
| New | +$27K | ﹤0.01% | 2424 |
|
2021
Q1 | – | Sell |
-2,292
| Closed | -$32K | – | 2596 |
|
2020
Q4 | $32K | Hold |
2,292
| – | – | ﹤0.01% | 2428 |
|
2020
Q3 | $36K | Hold |
2,292
| – | – | ﹤0.01% | 2260 |
|
2020
Q2 | $40K | Buy |
2,292
+1,837
| +404% | +$32.1K | ﹤0.01% | 2292 |
|
2020
Q1 | $6K | Hold |
455
| – | – | ﹤0.01% | 2554 |
|
2019
Q4 | $11K | Buy |
+455
| New | +$11K | ﹤0.01% | 2573 |
|
2019
Q3 | – | Sell |
-858
| Closed | -$21K | – | 1382 |
|
2019
Q2 | $21K | Buy |
+858
| New | +$21K | ﹤0.01% | 2580 |
|